First Trust launches first Bitcoin Strategy ETFs
First Trust Advisors has unveiled two new Bitcoin strategy exchange-traded funds, adding to a suite of products that currently hold more than $28 billion in net assets.
In an announcement on April 4, First Trust said it launched the two Bitcoin ( BTC ) strategy ETFs this week.
Specifically, the bitcoin exchange-traded funds are part of the the Floor15 ETF Series of Target Outcome ETFs, with both the FT Vest Bitcoin Strategy Floor15 ETF – April and the FT Vest Bitcoin Strategy & Target Income ETF listed on the NYSE Arca under tickers BFAP and DFII respectively.
“The FT Vest Bitcoin Strategy Floor15 ETF – April represents an innovative step forward in risk-managed cryptocurrency investing. By structuring investments with a defined floor and upside cap, we provide investors with a more controlled way to engage with bitcoin while mitigating downside exposure. This strategy reflects Vest’s commitment to outcome-focused solutions that seek to deliver more certainty and clarity to portfolios,” said Jeff Chang, president of Vest.
Ryan Issakainen, senior vice president and ETF strategist at First Trust, said the launch follows years of demand for bitcoin-linked ETFs. BFAP will allow those seeking to participate in the crypto space a chance to tap into BTC’s upside potential with clarity on downside risk.
As well as BFAP, First Trust believes DFII will gain traction for its potential. The fund, as Issakainen noted in a statement, will allow investors to explore opportunities around Bitcoin’s high volatility. Investors can look to generate income from this by selling call options.
The asset manager offers DFII as an actively managed fund, with 80% of net assets invested in bitcoin and income-generating investments. First Trust’s Target Outcome ETFs have seen a 53% spike in net assets in the past year, with over $28 billion as of the end of February.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Ripple XRP Is No Longer Just A Payments – Here’s 6 Reasons Why
Hacker moves $182K in ETH to Tornado Cash after Voltage exploit

Florida backs out of the Bitcoin game, no reserve
Corporate Crypto Eye $330B—Analysts Say Qubetics, Ethereum, and Injective Are Top Cryptos to Buy This Month
With $330B in corporate crypto demand forecasted, Qubetics, Ethereum, and Injective are standing out. Learn why analysts see Qubetics' $16.7M presale as a top crypto presale and how its cross-border utility redefines real-world blockchain adoption.Cross-Border Simplicity: How Qubetics Is Quietly Disrupting Global TransactionsEthereum Approaches Spectra Upgrade Amid Signs of Imminent VolatilityInjective Gathers Steam with Technical Surge and Bullish OutlookConclusion—And These Are the Top Cryptos to Buy Thi

Trending news
MoreCrypto prices
More








